Changing the Practice of Medicine
Popular
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
0.50 program credits
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
- MinuteCE®
Oral SERDs and PROTACs in ER+/HER2− mBC: Testing Smarter, Treating Better
0.50 credits 4 episodesKomal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Kathleen N. Moore, MD
Ritu Salani, MD
Kathleen N. Moore, MD
Ritu Salani, MD
Kathleen N. Moore, MD
Ritu Salani, MD
CME/CE
Komal Jhaveri, MD, FACP
Sara A. Hurvitz, MD, FACP
Tiffany Traina, MD
Ticiana Leal, MD
- MinuteCE®
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
0.50 program creditsNeal Ready, MD, PhD
Neal Ready, MD, PhD
Ticiana Leal, MD
- MinuteCE®
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
0.50 program creditsChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Clinical Practice
Kathleen N. Moore, MD
Ritu Salani, MD
Kathleen N. Moore, MD
Ritu Salani, MD
- MinuteCE®
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
0.50 program creditsTiciana Leal, MD
- MinuteCE®
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
0.50 program creditsChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
- MinuteCE®
Perioperative Immunotherapy in LA-HNSCC: From Evidence to Clinical Practice
0.50 credits 4 episodesChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Programs
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- MinuteCE®
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- MinuteCE®
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Tiffany Traina, MD